Want to see SG:M14 full AI Analyst Report?
Top Page
Innotek Limited
(SGX:M14)
Select Model
Select Model
Rating:47Neutral
Price Target:
S$0.43
▼(-34.39% Downside)
Action:Reiterated
Date:08/19/26
The score is held down primarily by weakened financial performance (steep TTM revenue decline and very thin margins) and bearish technicals (price below key moving averages with negative MACD). Valuation also screens unfavorably due to a high P/E, with the dividend yield providing only a partial offset.
Positive Factors
Manageable Leverage
Moderate and improving leverage gives Innotek financial flexibility through a weak earnings cycle. Debt is modest relative to assets and equity, reducing balance-sheet risk and limiting the likelihood that interest obligations constrain future investment.
Negative Factors
Severe Revenue Contraction
A revenue decline of this magnitude signals a major demand, pricing, or business-cycle reset. Sustained lower sales would reduce fixed-cost absorption, weaken customer and supplier leverage, and make a durable recovery in earnings materially more difficult.
Read all positive and negative factors
Positive Factors
Negative Factors
Manageable Leverage
Moderate and improving leverage gives Innotek financial flexibility through a weak earnings cycle. Debt is modest relative to assets and equity, reducing balance-sheet risk and limiting the likelihood that interest obligations constrain future investment.
Read all positive factors
Innotek Limited (M14) vs. iShares MSCI Singapore ETF (EWS)
Market Cap
S$112.18M
Dividend Yield4.6%
Average Volume (3M)1.72M
Price to Earnings (P/E)58.8
Beta (1Y)0.75
Revenue Growth-5.54%
EPS Growth-43.18%
CountrySG
Employees1,867
SectorIndustrials
Sector Strength72
IndustryManufacturing - Metal Fabrication
Share Statistics
EPS (TTM)<0.01
Shares Outstanding271,256,800
10 Day Avg. Volume4,250,800
30 Day Avg. Volume1,724,573
Financial Highlights & Ratios
PEG Ratio-1.15
Price to Book (P/B)0.88
Price to Sales (P/S)0.71
P/FCF Ratio337.82
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.03
Revenue Forecast (FY)S$231.00M
Innotek Limited Business Overview & Revenue Model
Company Description
Headquartered in Singapore, InnoTek Limited is an investment holding company established in 1995 that specializes in the production of precision metal components. Its operational footprint extends across Singapore, Hong Kong, the People's Republic...
Innotek Limited Financial Statement Overview
Summary
Income Statement
38
Negative
Balance Sheet
72
Positive
Cash Flow
56
Neutral
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 206.88M | 209.91M | 238.03M | 205.56M | 186.75M | 173.58M |
| Gross Profit | 29.09M | 25.66M | 36.44M | 32.96M | 27.19M | 33.69M |
| EBITDA | 5.32M | 9.79M | 22.26M | 15.51M | 15.89M | 22.89M |
| Net Income | 1.74M | 2.00M | 5.80M | 4.66M | 2.25M | 11.51M |
Balance Sheet | ||||||
| Total Assets | 303.03M | 278.96M | 262.79M | 264.08M | 258.38M | 267.04M |
| Cash, Cash Equivalents and Short-Term Investments | 80.06M | 67.04M | 70.10M | 70.28M | 77.46M | 90.70M |
| Total Debt | 38.69M | 55.02M | 18.84M | 24.20M | 19.00M | 23.90M |
| Total Liabilities | 118.25M | 107.71M | 86.61M | 90.75M | 81.68M | 77.20M |
| Stockholders Equity | 184.79M | 171.25M | 175.50M | 172.34M | 176.70M | 189.84M |
Cash Flow | ||||||
| Free Cash Flow | 1.54M | 444.00K | 7.86M | -5.24M | -1.41M | 5.14M |
| Operating Cash Flow | 15.82M | 10.70M | 21.54M | 7.84M | 5.58M | 12.32M |
| Investing Cash Flow | -9.33M | -7.38M | -9.54M | -13.32M | -7.11M | -6.50M |
| Financing Cash Flow | 9.47M | -3.88M | -11.02M | -1.48M | -9.19M | -8.78M |
Innotek Limited Technical Analysis
Negative
0.66
Price Trends
0.57
Negative
0.67
Negative
0.68
Negative
Market Momentum
-0.04
Positive
31.95
Neutral
11.86
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SG:M14, the sentiment is Negative. The current price of 0.66 is above the 20-day moving average (MA) of 0.49, above the 50-day MA of 0.57, and below the 200-day MA of 0.68, indicating a bearish trend. The MACD of -0.04 indicates Positive momentum. The RSI at 31.95 is Neutral, neither overbought nor oversold. The STOCH value of 11.86 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SG:M14.
Innotek Limited Peers Comparison
UnderperformOutperform
Sector (63)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
64 Neutral | S$59.09M | 11.86 | 5.92% | 1.02% | -5.67% | 50.90% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
51 Neutral | S$241.64M | 13.82 | 7.84% | 4.43% | 19.95% | -25.59% | |
47 Neutral | S$112.18M | 58.78 | 0.98% | 3.12% | -5.54% | -43.18% | |
47 Neutral | S$60.35M | 25.63 | 1.31% | 1.57% | ― | ― |
* Industrials Sector Average
SG:M14
Innotek Limited
0.44
0.06
15.69%
SG:BTJ
A-Sonic Aerospace
0.59
0.27
86.12%
SG:G0I
Nam Lee Pressed Metal Industries Limited
0.59
0.13
27.16%
SG:500
Tai Sin Electric Limited
0.53
<0.01
0.38%
SG:BKX
Yongmao Holdings Limited
0.68
0.03
4.62%
SG:G20
GP Industries Limited
0.58
0.12
26.37%
Innotek Limited Corporate Events
InnoTek taps S$16m to expand Southeast Asian manufacturing and pivot toward AI and EV growth
Aug 14, 2026
InnoTek has strengthened its balance sheet with a S$16.0 million private placement, channeling the funds into a regional manufacturing build-out that includes new and expanded precision component facilities in Thailand and Malaysia to support liqu...
Innotek Shareholders Back Board, Dividend and New Share Mandate at 30th AGM
May 26, 2026
Innotek Limited held its 30th annual general meeting in Singapore on 29 April 2026, where the board presented the group’s performance for the financial year ended 31 December 2025 and confirmed that all resolutions would be conducted by poll...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.